Here are the top stories from the last week:

Industry Updates

Independent pharmacy groups back Iowa PBM regulation in federal court
The independent pharmacy groups say PBMs aren’t employee benefits plans. They’re merely administrators hired by the plans, and so they can be regulated.
Read article »

CDC pulls support for COVID vaccine
The CDC said COVID-19 shots should be administered through shared decision-making with a healthcare provider.
Read article »

Helping pharmacists strengthen connections and improve care through mental health training
A partnership between the Cardinal Health Foundation and the National Community Pharmacists Association (NCPA) Innovation Center provides mental health resources to help pharmacists support the needs of their patients and the well-being of their staff.
Read article »

Pharmacies Feeling the Pinch From Low GLP-1 Reimbursement
GLP-1 medications are often excluded from coverage in employer health plans, and coverage is expected to decline even more during 2025 and beyond.
Read article »

Tramadol and Antidepressants Linked to Increased Seizure Risk in Older Adults
A study of 70,156 nursing home residents revealed higher seizure rates with tramadol and CYP2D6-inhibiting antidepressants compared to other antidepressants.
Read article »

How a Government Shutdown Could Delay FDA Actions, Disrupt Pharmacy Operations
Lawyers pharmacies to maintain compliance, explore contingency options, and stay engaged with policymakers during the government shutdown.
Read article »

Addressing Inequities in Food Allergy Prevention and Treatment
Socioeconomically disadvantaged families have higher rates of food allergies compared with the general population. However, their needs are not being met adequately under the current healthcare system.
Read article »

Treatment & Technology Updates

FDA approves Evita Solution’s generic abortion pill
The Food and Drug Administration approved Evita Solutions’ generic mifepristone tablets, just before the government shutdown, per a CNBC report.
Read article »

Celltrion launches Actemra biosimilar
Avtozma is used to treat rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis and other ailments.
Read article »

‍

‍

‍